Ursprung des Netzwerks ersten Grades von Nicholas C. Babson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Zurex PharmAgra LLC
2
| Subsidiary | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicholas C. Babson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Biotechnology | Director/Board Member | |
Southwestern Oklahoma State University | College/University | Undergraduate Degree | |
Medeva Pharmaceuticals, Inc.
Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Pharmaceuticals: Major | General Counsel | |
Zurex Pharma, Inc.
Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Medical Specialties | General Counsel | |
Celltech Pharmaceuticals, Inc. | General Counsel |
Statistik
International
Vereinigte Staaten | 8 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Operativ
General Counsel | 5 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Roy Andrew Morgan | 8 |
Mike Pawlak | 1 |
- Börse
- Insiders
- Nicholas C. Babson
- Unternehmensverbindungen